These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3463813)

  • 1. [Complete remission achieved by high dose cytosine arabinoside therapy in the 4th relapse of AML].
    Sai M; Naganuma Y; Aoki I; Toyama K
    Rinsho Ketsueki; 1986 Jun; 27(6):952-5. PubMed ID: 3463813
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of refractory leukemia with high-dose cytosine arabinoside.
    Klener P; Háber J
    Neoplasma; 1985; 32(1):113-7. PubMed ID: 3856754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission.
    Stone RM; DeAngelo DJ; Janosova A; Galinsky I; Canning C; Ritz J; Soiffer RJ
    Am J Hematol; 2008 Oct; 83(10):771-7. PubMed ID: 18756547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.
    Baer MR; Christiansen NP; Frankel SR; Brunetto VL; Mrózek K; Bloomfield CD; Herzig GP
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):6-12. PubMed ID: 7507264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
    Bloomfield CD; Lawrence D; Byrd JC; Carroll A; Pettenati MJ; Tantravahi R; Patil SR; Davey FR; Berg DT; Schiffer CA; Arthur DC; Mayer RJ
    Cancer Res; 1998 Sep; 58(18):4173-9. PubMed ID: 9751631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine and cytosine-arabinoside for poor-risk acute myeloid leukemia.
    Russo D; Candoni A; Grattoni R; Bertone A; Zaja F
    Haematologica; 1998 Mar; 83(3):281-2. PubMed ID: 9573683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy of chronic myelogenous leukemia in blastic crisis--vindesine, cytosine arabinoside prednisolone combination therapy].
    Uzuka Y; Saito Y; Takahash H; Komatsu M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1064-70. PubMed ID: 6586112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia.
    Bassan R; Lerede T; Buelli M; Borleri G; Bellavita P; Rambaldi A; Barbui T
    Haematologica; 1998 May; 83(5):422-7. PubMed ID: 9658726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.
    Clavio M; Venturino C; Pierri I; Garrone A; Miglino M; Canepa L; Balleari E; Balocco M; Michelis GL; Ballerini F; Gobbi M
    Ann Hematol; 2004 Nov; 83(11):696-703. PubMed ID: 15322763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside].
    Patterson D; Kravtsova VM; Petrova EM; Zabelina TS; Balaian LN
    Ter Arkh; 1987; 59(12):81-6. PubMed ID: 3482131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High antileukemic activity of sequential high dose cytosine arabinoside and mitoxantrone in patients with refractory acute leukemias. Results of a clinical phase II study.
    Kern W; Schleyer E; Unterhalt M; Wörmann B; Büchner T; Hiddemann W
    Cancer; 1997 Jan; 79(1):59-68. PubMed ID: 8988727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complete remission obtained in a child with relapse of erythroleukemia by low-dose cytosine arabinoside].
    Miyazaki M; Sato J; Hirose M; Ninomiya T; Miyao M
    Rinsho Ketsueki; 1986 Jun; 27(6):916-9. PubMed ID: 3463809
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolated hyperbilirubinemia following standard dose cytosine arabinoside in a patient with relapsed acute myeloid leukemia.
    Altundag O; Altundag K; Celik I; Turker A; Kars A
    Am J Hematol; 2004 Apr; 75(4):263-4. PubMed ID: 15054828
    [No Abstract]   [Full Text] [Related]  

  • 14. Low dose cytarabine and Granulocyte / Macrophage-Colony Stimulating Factor induced long-term remission in a patient with acute myeloid leukemia in early relapse after intensive chemotherapy.
    Sastre JL; Ulibarrena C; Cantón I; Iglesias M; García-Torremocha S; Vázquez MO
    Haematologica; 2000; 85(E-letters):E09. PubMed ID: 11114824
    [No Abstract]   [Full Text] [Related]  

  • 15. Low dose cytosine arabinoside in acute myeloid leukemia: remission is not due to differentiation induction.
    Pinkerton PH; London B; Cowan DH
    Am J Hematol; 1985 Aug; 19(4):415-7. PubMed ID: 3861090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose cytosine arabinoside in adult chronic myelomonocytic leukemia.
    Fenaux P; Jouet JP; Bauters F
    J Clin Oncol; 1987 Jul; 5(7):1129-30. PubMed ID: 3474358
    [No Abstract]   [Full Text] [Related]  

  • 17. Idarubicin, high-dose cytarabine, and etoposide for induction of remission in acute leukemia.
    Mehta J; Powles R; Singhal S; Horton C; Hamblin M; Zomas A; Saso R; Prendiville J; Glynne P; Allford S; Mackay H; Treleaven J
    Semin Hematol; 1996 Oct; 33(4 Suppl 3):18-23. PubMed ID: 8916312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High doses of cytosine arabinoside in the treatment of refractory leukemia].
    Klener P; Háber J; Kolesková E
    Sb Lek; 1987 Sep; 89(8-9):271-5. PubMed ID: 3478794
    [No Abstract]   [Full Text] [Related]  

  • 19. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
    Farag SS; Ruppert AS; Mrózek K; Mayer RJ; Stone RM; Carroll AJ; Powell BL; Moore JO; Pettenati MJ; Koduru PR; Stamberg J; Baer MR; Block AW; Vardiman JW; Kolitz JE; Schiffer CA; Larson RA; Bloomfield CD
    J Clin Oncol; 2005 Jan; 23(3):482-93. PubMed ID: 15534356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.